Doctors in Florida warned a woman died from dengue fever earlier this month as Hillsborough County health officials track 95 locally acquired cases.
The family of the deceased woman reported her diagnosis to local news outlets after physicians attributed her death to the mosquito-borne illness. While the Florida Department of Health has not yet confirmed the official cause of death, the Hillsborough County Health Department issued a mosquito-borne illness alert in August 2026 following reports of multiple locally acquired infections.
Health authorities noted that the cluster of locally transmitted cases serves as a stark reminder that dengue fever is increasingly being contracted within the United States rather than solely during overseas travel.
Dengue fever is widely known as breakbone fever due to the intense discomfort it inflicts. Patients typically experience a sudden high fever accompanied by a pounding headache, severe pain behind the eyes, and deep aches throughout their muscles, joints, and bones. Many individuals also suffer from nausea, vomiting, or a blotchy skin rash several days after falling ill.
Hillsborough County, which encompasses the city of Tampa along the Gulf Coast of Florida, has seen 95 documented dengue cases since July 2026. Because the virus is frequently associated with international travel, medical providers in regions where dengue remains uncommon can easily misdiagnose the illness as influenza or COVID-19. Public health experts warn that delays in proper diagnosis and medical intervention can lead to dangerous complications.
Mosquito Transmission and Infection Cycles
Dengue does not spread directly from person to person like a common cold or respiratory virus. Instead, transmission occurs when infected Aedes mosquitoes, primarily the species Aedes aegypti, bite human hosts. Aedes aegypti mosquitoes are widely established across Florida and thrive in warm, densely populated urban environments, where females can lay eggs in containers holding as little as a bottle capful of standing water. Unlike many other mosquito species, they actively bite during daytime hours rather than restricting their feeding to dusk or dawn.
The transmission cycle begins when a mosquito feeds on an infected individual and subsequently transmits the virus to another person several days later. The infection presents significant containment challenges because approximately three out of four infected people remain completely asymptomatic. For the 25 percent of patients who do develop symptoms, signs of illness typically appear four to ten days after receiving a mosquito bite.
Four distinct viral strains of dengue exist worldwide. Infection with one strain grants long-term immunity against that specific strain only. Contracting a second infection with a different strain significantly increases the risk of developing severe, potentially fatal complications.
Complications and Severe Dengue Risks
While most dengue patients endure a painful week of illness before recovering independently, approximately one in 20 patients develops severe dengue. This life-threatening progression often emerges just as the initial fever subsides, typically between days three and seven of the illness, creating a false impression that the patient is recovering.
During severe dengue, microscopic blood vessels throughout the body begin leaking fluid into surrounding tissues. This fluid leakage can cause blood pressure to crash rapidly, leading to dangerous internal bleeding, shock, and major organ failure. Crucial warning signs of severe disease include severe abdominal pain, persistent vomiting, bleeding from the gums or nose, blood in vomit or stool, and extreme drowsiness or restlessness.
Certain demographic groups face a heightened risk of developing severe dengue complications. Vulnerable populations include infants, pregnant women, adults over 65 years old, and individuals with underlying medical conditions such as diabetes, obesity, or kidney disease. Without medical intervention, severe dengue carries a mortality rate of up to 10 percent. However, rapid hospital admission and supportive care reduce the fatality rate to less than one in 100 patients.
A dengue vaccine is currently manufactured and available, but public health guidelines do not recommend it for average American travelers. Medical authorities restrict vaccine administration to select groups, specifically children living in high-transmission areas who have previously documented dengue infections. Consequently, public safety depends primarily on preventative measures to avoid mosquito bites.
Medical Treatment and Hospital Care
No specific antiviral medication exists to cure dengue fever. Medical management focuses entirely on supportive care while the patient's immune system clears the virus. For mild cases managed at home, physicians recommend rest, heavy fluid intake, and acetaminophen to control fever and body pain.
Patients suspected of having dengue must strictly avoid aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs (NSAIDs). NSAIDs interfere with blood clotting and significantly increase the risk of severe internal bleeding in dengue patients. When patients develop severe symptoms, emergency hospital admission is required to administer intravenous fluids under close monitoring. Precise fluid regulation is critical, as insufficient fluid delivery can precipitate fatal shock, while excessive fluids can flood the lungs.
Global Surge and United States Cases
The outbreak in Florida forms part of a dramatic global surge in dengue infections. According to the World Health Organization, international health agencies recorded over 14 million dengue cases in 2024, marking the worst year on record across approximately 100 countries. This figure represents a 2,600 percent increase compared to the 505,000 cases reported globally in 2000.
Global public health researchers attribute the expanding geographic range of mosquitoes and the virus to rising global temperatures, rapid urbanization, and increased international travel. While South Asia, Southeast Asia, and Latin America suffer the heaviest disease burden, dengue transmission is steadily expanding northward into temperate zones.
The vast majority of dengue cases diagnosed within the contiguous United States originate from overseas travel. Data from the Centers for Disease Control and Prevention showed nearly 1,900 travel-related dengue infections nationwide in 2023. Within the contiguous US, health authorities have identified 346 travel-associated cases and 73 locally acquired cases, with 72 of those local infections occurring in Florida.
Among US jurisdictions, Puerto Rico and the US Virgin Islands report the highest overall volume of dengue cases. Within the 50 states, Florida carries the highest risk of local transmission, led by Miami-Dade County, which recorded more than 300 locally acquired cases between 2010 and 2024. Locally acquired dengue cases have also been identified in Texas, California, Arizona, and Hawaii.
Prevention Guidelines and Public Safety
Public health experts advise anyone who develops a sudden fever after traveling to endemic regions or experiencing mosquito bites in South Florida to consult a doctor immediately and disclose their travel history. Individuals exhibiting warning signs such as severe stomach pain, persistent vomiting, mucosal bleeding, or severe lethargy should seek immediate emergency medical care.
To reduce transmission risks, residents are urged to apply EPA-approved insect repellent, wear protective long-sleeved clothing, and regularly empty standing water from containers in yards and outdoor spaces where mosquitoes reproduce.
This report incorporates findings originally published in The Conversation by Andrés Henao, a professor of medicine and infectious disease at the University of Colorado Anschutz, and edited by Alexa Lardieri, the US health editor at the Daily Mail.
